Alast Ahmadi

Internal Medicine
101 The City Dr S
Orange, CA 92868

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications

Examining patient perspectives on low-value care: Findings from a survey on preoperative testing for cataract surgery.

Examining patient perspectives on low-value care: Findings from a survey on preoperative testing for cataract surgery.

Journal: Journal of the American Geriatrics Society
Published: May 31, 2023

Protocol for pragmatic randomised trial: integrating electronic health record-based behavioural economic 'nudges' into the electronic health record to reduce preoperative testing for patients undergoing cataract surgery.

Protocol for pragmatic randomised trial: integrating electronic health record-based behavioural economic 'nudges' into the electronic health record to reduce preoperative testing for patients undergoing cataract surgery.

Journal: BMJ open
Published: November 04, 2021

Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist.

Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 04, 2018

Structure-Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands.

Structure-Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands.

Journal: Journal of medicinal chemistry
Published: October 20, 2017

Identification of Biologically Active Pyrimido[5,4-b]indoles That Prolong NF-κB Activation without Intrinsic Activity.

Identification of Biologically Active Pyrimido[5,4-b]indoles That Prolong NF-κB Activation without Intrinsic Activity.

Journal: ACS combinatorial science
Published: June 29, 2017

Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.

Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer.

Journal: JCI insight
Published: February 17, 2017
Showing 1-6 of 6

Last Updated: 09/26/2026